1Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension[J]. Am J Pathol, 1994,144:275 - 285.
2Johnson SR, Gladman DD, Urowitz MB, et al. Pulmonary hypertension in systemic lupus[J]. Lupus,2004,13:506 - 509.
3Williams MH, Das C, Handler CE, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era [ J ]. Heart, 2006,92:926 - 932.
4McGoon M, Gutterman D, Steen V, et al. Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines[J]. Ches, 2004,126:14S- 34.
5Okawa T, Aotsuka, Fujinami, et al. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 ( ELAM- 1) and class Ⅱ MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein[J]. Clinical & Experimental Immunology, 1999,116:174- 180.
6Krings P, Koncrza T, Neumann T, et al. Competence Network of Heart F, Pulmonary arterial hypertension related to HIV infection a systematic review of the literature comprising 192 cases[J]. Current Medical Research and Opinion, 2007,23:63 - 69.
7Lesprit PHIL, Godeau BERT. Pulmonary Hypertension in POEMS Syndrome. A New Feature Mediated by Cytokines[J]. American Journal of Respiratory and Critical Care Medicine, 1998,157:907- 911.
8Opravil M, Pechere M, Speich R, et al. FIIV-associated primary pulmonary hypertension. A case control study Swiss FIIV Cohort Study [ J]. Am J Respir Crit Care Med, 1997,155:990-995.
9Humbert M, Monfi G, Fartoukh M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension comparison of HIV seropositive and HIV seronegative patients [ J]. European Respiratory Journal, 1998,11:554 - 559.
10Zlotnik A, Yoshie O. Chemokines: A New Classification System and Their Role in Immunity[J]. Immunity, 2000,12:121 - 127.
